Hemant Surgical Industries IPO vs Remus Pharmaceuticals IPO

Comparision between Hemant Surgical Industries IPO and Remus Pharmaceuticals IPO.

IPO Details

Hemant Surgical Industries IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Hem Securities Limited	Beeline Capital Advisors Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Link Intime India Private Ltd
Market Maker	Hem Finlease Private Limited	Sunflower Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Hemant Surgical Industries IPO is up to ₹24.84 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Hemant Surgical Industries IPO is ₹90.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

	Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹85.00 per share	₹1,150.00 per share
Issue Price (Upper)	₹90.00 per share	₹1,229.00 per share
Issue Price (Final)	₹90.00 per share	₹1,229.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1600 shares	100 shares
Fresh Issue Size	27,60,000 shares	3,88,000 shares
Fresh Issue Size (Amount)	up to ₹24.84 Cr	up to ₹47.69 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	27,60,000 shares	3,88,000 shares
Issue Size Total (Amount)	up to ₹24.84 Cr	up to ₹47.69 Cr

IPO Timetable

Hemant Surgical Industries IPO opens on May 24, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Hemant Surgical Industries IPO and Remus Pharmaceuticals IPO is May 26, 2023, and May 19, 2023, respectively.

	Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
Anchor Bid Date	May 23, 2023	May 16, 2023
Issue Open	May 24, 2023	May 17, 2023
Issue Close	May 26, 2023	May 19, 2023
Basis Of Allotment (Tentative)	May 31, 2023	May 24, 2023
Initiation of Refunds (Tentative)	Jun 01, 2023	May 25, 2023
Credit of Share (Tentative)	Jun 02, 2023	May 26, 2023
Listing date (Tentative)	Jun 05, 2023	May 29, 2023
Anchor Lockin End date 1	Jun 30, 2023	Jun 23, 2023
Anchor Lockin End date 2	Aug 29, 2023	Aug 22, 2023

Financials

Hemant Surgical Industries IPO P/E ratio is 12.28, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

Hemant Surgical Industries IPO

Remus Pharmaceuticals IPO

Financial

Hemant Surgical Industries Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-21	4,289.84	6,065.19	114.53	836.61	653.38	1,446.35
31-Mar-22	5,437.59	10,577.02	461.40	1,298.01	1,114.78	973.80
31-Mar-23	6,490.79	11,149.68	765.11	2,359.90	1,591.90	711.92
Amount in ₹ Lakhs

Remus Pharmaceuticals Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	530.36	1,276.89	81.16	202.03	201.03	35.93
31-Mar-21	1,104.96	1,922.45	102.58	304.61	303.61	27.89
31-Mar-22	1,590.93	2,543.71	338.57	643.17	543.17	19.17
31-Dec-22	3,352.96	3,361.20	643.90	1,712.07	1,603.57	947.45
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100.00%

92.82%

Promoter Shareholding (Post-Issue)

73.56%

68.37%

P/E Ratio

12.28

21.09

Market Cap

₹93.96 Cr.

₹181.03 Cr.

ROE

32.42%%

71.44%%

ROCE

37.98%%

69.99%%

Debt/Equity

0.3

0.03

EPS

₹10.26

₹33.86

RoNW

32.42%%

52.64%%

Shares Offered

In the Hemant Surgical Industries IPO retail investors (RII) are offered 9,16,800 shares while in Remus Pharmaceuticals IPO retail investors are offered 9,16,800 shares. Qualified institutional buyers (QIB) are offered 5,23,200 shares in Hemant Surgical Industries IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.

	Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
Anchor Investor Reserveration	7,82,400 shares	1,10,500 shares
Market Maker Reserveration	1,44,000 shares	19,500 shares
QIB	5,23,200 shares	1,38,750 shares
NII	3,93,600 shares	41,625 shares
RII	9,16,800 shares	97,125 shares
Employee	0 shares	0 shares
Others
Total	18,33,600 shares	2,77,500 shares

Bids Received (Subscription)

Hemant Surgical Industries IPO subscribed 150.59x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

	Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
QIB (times)	41.05x	10.75x
NII (times)	277.26x	229.31x
Big NII (times)
Small NII (times)
RII (times)	158.73x	49.81x
Employee (times)
Other (times)
Total (times)	150.59x	57.21x

Compare with others

Hemant Surgical Industries IPO	Remus Pharmaceuticals IPO
Sahana System IPO	Proventus Agrocom IPO
CFF Fluid Control IPO	Hemant Surgical Industries IPO
Comrade Appliances IPO	Vasa Denticity IPO
Infollion Research Services IPO	Spectrum Talent Management IPO
Proventus Agrocom IPO	Crayons Advertising IPO
Vasa Denticity IPO	Auro Impex & Chemicals IPO
Spectrum Talent Management IPO	Innokaiz India IPO
Crayons Advertising IPO	Krishca Strapping Solutions IPO
Remus Pharmaceuticals IPO	De Neers Tools IPO
Auro Impex & Chemicals IPO	Quicktouch Technologies IPO

Comments

Add a public comment...